Spain: Ysios Capital targets 15 investments from close of €216m third fund
Spain-based biotech venture capital firm, Ysios Capital, has closed its third fund, Ysios BioFund 3 (YBF 3) at €216m (US$264m).
Its largest fund to date,...
InfraVia acquires Mater Private
French infrastructure investment company InfraVia Capital Partners has agreed to buy Ireland’s Mater Private hospital group from US fund HarbourVest Partners for an undisclosed...
MIG agrees to sell Hygeia to CVC
Marfin Investment Group (MIG) has agreed to sell its Greek hospital business Hygeia to CVC Capital Partners-backed Hellenic Healthcare for €204.4m, blowing out of...
NMC Health reiterates guidance after rating downgraded
NMC Health has reiterated its guidance for 2018 and 2019, saying management remains comfortable with anticipated year-on-year EBITDA growth of 36% in 2018 and...
Ukraine: IFC to strengthen Lviv’s healthcare sector through PPPs
In a bid to increase private sector participation in health, promote innovative technologies and create a robust health-care system IFC (a member of the...
Six BMI hospital properties under offer
Six BMI Healthcare hospital properties are under offer to an unnamed bidder, marking what is believed to be Netcare’s final exit from the UK...
Alliance Medical sold to iCON Infrastructure
South African healthcare giant Life Healthcare has entered into a binding agreement to sell Alliance Medical Group (AMG) to independent investment firm iCON Infrastructure for £910m.
The...
Kaia Health partners with pharma company
Digital therapeutics provider Kaia Health has partnered with Italian pharmaceutical company Chiesi Group to offer its Kaia Health Chronic Obstructive Pulmonary Disease (COPD) rehabilitation...
Georgia Healthcare revenue grows 13.3% in Q3
Georgia Healthcare Group (GHG) has reported a revenue increase of 13.3% for the third quarter of 2018, with ‘good’ results across all areas of the...
Ramsay ups bid for Capio
Ramsay Health Care has upped its offer to buy pan-European healthcare company Capio AB (Capio) from €661m to €783m.
The Australian healthcare giant previously resisted...